Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Kathryn E Wengel is Director at Johnson & Johnson. OQRO lists 24 transactions filed with the SEC under this name, the latest on Jun 12, 2026, each linked to the official Form 4.
Director
Disclosures on record
24
Companies involved
2
As of the latest filing on , Kathryn E Wengel reported holding 114,288 shares of Johnson & Johnson (JNJ), worth about $31.2M at the last close of $273 (Nov 18, 2026). Holdings are also on file at Labcorp (LH); together they are worth about $32.7M. In the last 12 months, Kathryn E Wengel sold $2.41M in 1 sale.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Johnson & Johnson JNJ | 114,288 | 114K direct | $273 | $31.2M | Jun 11, 2026 |
| Labcorp LH | 4,133 | 4,133 direct | $371 | $1.53M | Feb 11, 2026 |
Is this Kathryn E Wengel’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Johnson & JohnsonJNJ
21 disclosures · Feb 2026 – Jun 2026 · 1 sold
Jun 11, 2026Sold~$2.41Mdisclosed Jun 12
DetailsOfficial recordJun 11, 202610Kdisclosed Jun 12
DetailsOfficial recordJun 11, 202610Kdisclosed Jun 12
DetailsOfficial recordFeb 15, 202617Kdisclosed Feb 19
DetailsOfficial recordFeb 15, 20261,217disclosed Feb 19
DetailsOfficial recordFeb 13, 202614Kdisclosed Feb 19
DetailsOfficial recordFeb 13, 2026651disclosed Feb 19
DetailsOfficial recordFeb 13, 202614Kdisclosed Feb 19
DetailsOfficial recordFeb 15, 2026606disclosed Feb 19
DetailsOfficial recordFeb 15, 2026635disclosed Feb 19
DetailsOfficial recordFeb 13, 2026651disclosed Feb 19
DetailsOfficial recordFeb 15, 2026606disclosed Feb 19
DetailsOfficial recordFeb 15, 2026635disclosed Feb 19
DetailsOfficial recordFeb 15, 2026310disclosed Feb 19
DetailsOfficial recordFeb 15, 2026325disclosed Feb 19
DetailsOfficial recordFeb 13, 20266,414disclosed Feb 19
DetailsOfficial recordFeb 13, 2026217disclosed Feb 19
DetailsOfficial recordFeb 9, 202614Kdisclosed Feb 12
DetailsOfficial recordFeb 6, 202639Kdisclosed Feb 10
DetailsOfficial recordFeb 6, 202639Kdisclosed Feb 10
DetailsOfficial recordFeb 6, 202627Kdisclosed Feb 10
DetailsOfficial recordLabcorpLH
3 disclosures · Feb 2026
Feb 11, 2026897disclosed Feb 13
DetailsOfficial recordFeb 11, 2026897disclosed Feb 13
DetailsOfficial recordFeb 10, 2026773disclosed Feb 12
DetailsOfficial recordKathryn E Wengel has no open-market purchase on record since 2019. Sales in 5 of the 8 years since 2019.
Kathryn E Wengel reported 0 open-market purchases and 10 sales since 2019; no open-market purchase.
| Year | Bought | Sold |
|---|---|---|
| 2026 | — | $2.41M1×1 trade |
| 2023 | — | $1.99M1×1 trade |
| 2022 | — | $9.77M5×5 trades |
| 2020 | — | $2.47M2×2 trades |
| 2019 | — | $285K1×1 trade |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
On the latest SEC Form 4, dated Jun 11, 2026, Kathryn E Wengel reported holding 114,288 shares of Johnson & Johnson (JNJ). At the last close of $273 on Nov 18, 2026, that is about $31.2M. This is the stake disclosed in filings, not a net worth.
No public filing gives Kathryn E Wengel's net worth. What SEC Form 4 shows is the stock stake: 114,288 shares of Johnson & Johnson (JNJ), about $31.2M at the last close, plus holdings in 1 other company, about $32.7M in all. Cash, other investments, property, debts and unexercised options are not in these filings, so the real figure can be much higher or lower.
In SEC filings of the last 12 months, Kathryn E Wengel reported 1 open-market sale worth $2.41M, and no open-market purchase. Shares withheld for taxes, gifts and option exercises are not counted in these totals.
Kathryn E Wengel has no open-market purchase on record since 2019. Sales in 5 of the 8 years since 2019.
In SEC filings since 2019: no open-market purchase is on record; the latest open-market sale is from 2026.
Johnson & Johnson (JNJ), from 2019 to 2026: 0 purchases and 10 sales.
Kathryn E Wengel reported 0 open-market purchases and 10 sales here, 2019 to 2026.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.